104 related articles for article (PubMed ID: 21161444)
1. Vasculogenic mimicry-potential target for glioblastoma therapy: an in vitro and in vivo study.
Chen Y; Jing Z; Luo C; Zhuang M; Xia J; Chen Z; Wang Y
Med Oncol; 2012 Mar; 29(1):324-31. PubMed ID: 21161444
[TBL] [Abstract][Full Text] [Related]
2. HNRNPA2B1 stabilizes NFATC3 levels to potentiate its combined actions with FOSL1 to mediate vasculogenic mimicry in GBM cells.
Wang H; Shi Y; Zhou X; Zhang L; Yang A; Zhou D; Ma T
Cell Biol Toxicol; 2024 Jun; 40(1):44. PubMed ID: 38862832
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma-derived tumor cells induce vasculogenic mimicry through Flk-1 protein activation.
Francescone R; Scully S; Bentley B; Yan W; Taylor SL; Oh D; Moral L; Shao R
J Biol Chem; 2012 Jul; 287(29):24821-31. PubMed ID: 22654102
[TBL] [Abstract][Full Text] [Related]
4. Tumor Vessels Fuel the Fire in Glioblastoma.
Rosińska S; Gavard J
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204510
[TBL] [Abstract][Full Text] [Related]
5. Shaping the brain vasculature in development and disease in the single-cell era.
Wälchli T; Bisschop J; Carmeliet P; Zadeh G; Monnier PP; De Bock K; Radovanovic I
Nat Rev Neurosci; 2023 May; 24(5):271-298. PubMed ID: 36941369
[TBL] [Abstract][Full Text] [Related]
6. CD133+ glioblastoma stem-like cells induce vascular mimicry in vivo.
Chiao MT; Yang YC; Cheng WY; Shen CC; Ko JL
Curr Neurovasc Res; 2011 Aug; 8(3):210-9. PubMed ID: 21675958
[TBL] [Abstract][Full Text] [Related]
7. Vasculogenic Mimicry Occurs at Low Levels in Primary and Recurrent Glioblastoma.
Maddison K; Faulkner S; Graves MC; Fay M; Bowden NA; Tooney PA
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568738
[TBL] [Abstract][Full Text] [Related]
8. Advances and Prospects of Vasculogenic Mimicry in Glioma: A Potential New Therapeutic Target?
Cai H; Liu W; Liu X; Li Z; Feng T; Xue Y; Liu Y
Onco Targets Ther; 2020; 13():4473-4483. PubMed ID: 32547078
[TBL] [Abstract][Full Text] [Related]
9. Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma.
Ahir BK; Engelhard HH; Lakka SS
Mol Neurobiol; 2020 May; 57(5):2461-2478. PubMed ID: 32152825
[TBL] [Abstract][Full Text] [Related]
10. Long Non-coding RNA LINC00339 Stimulates Glioma Vasculogenic Mimicry Formation by Regulating the miR-539-5p/TWIST1/MMPs Axis.
Guo J; Cai H; Liu X; Zheng J; Liu Y; Gong W; Chen J; Xi Z; Xue Y
Mol Ther Nucleic Acids; 2018 Mar; 10():170-186. PubMed ID: 29499931
[TBL] [Abstract][Full Text] [Related]
11. Impact of Blood Vessel Quantity and Vascular Expression of CD133 and ICAM-1 on Survival of Glioblastoma Patients.
Minajeva A; Kase M; Saretok M; Adamson-Raieste A; Kase S; Niinepuu K; Vardja M; Asser T; Jaal J
Neurosci J; 2017; 2017():5629563. PubMed ID: 29250531
[TBL] [Abstract][Full Text] [Related]
12. Aberrant glioblastoma neovascularization patterns and their correlation with DCE-MRI-derived parameters following temozolomide and bevacizumab treatment.
Xue W; Du X; Wu H; Liu H; Xie T; Tong H; Chen X; Guo Y; Zhang W
Sci Rep; 2017 Oct; 7(1):13894. PubMed ID: 29066764
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?
Ramjiawan RR; Griffioen AW; Duda DG
Angiogenesis; 2017 May; 20(2):185-204. PubMed ID: 28361267
[TBL] [Abstract][Full Text] [Related]
14. Vascular mimicry in glioblastoma following anti-angiogenic and anti-20-HETE therapies.
Angara K; Rashid MH; Shankar A; Ara R; Iskander A; Borin TF; Jain M; Achyut BR; Arbab AS
Histol Histopathol; 2017 Sep; 32(9):917-928. PubMed ID: 27990624
[TBL] [Abstract][Full Text] [Related]
15. Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma.
Ju RJ; Zeng F; Liu L; Mu LM; Xie HJ; Zhao Y; Yan Y; Wu JS; Hu YJ; Lu WL
Int J Nanomedicine; 2016; 11():1131-46. PubMed ID: 27042063
[TBL] [Abstract][Full Text] [Related]
16. Glioma Stem Cells: Signaling, Microenvironment, and Therapy.
Liebelt BD; Shingu T; Zhou X; Ren J; Shin SA; Hu J
Stem Cells Int; 2016; 2016():7849890. PubMed ID: 26880988
[TBL] [Abstract][Full Text] [Related]
17. Dual Receptor Recognizing Cell Penetrating Peptide for Selective Targeting, Efficient Intratumoral Diffusion and Synthesized Anti-Glioma Therapy.
Liu Y; Mei L; Xu C; Yu Q; Shi K; Zhang L; Wang Y; Zhang Q; Gao H; Zhang Z; He Q
Theranostics; 2016; 6(2):177-91. PubMed ID: 26877777
[TBL] [Abstract][Full Text] [Related]
18. Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization.
Shao R; Taylor SL; Oh DS; Schwartz LM
Oncotarget; 2015 Dec; 6(38):40507-18. PubMed ID: 26439689
[TBL] [Abstract][Full Text] [Related]
19. Glioblastoma vasculogenic mimicry: signaling pathways progression and potential anti-angiogenesis targets.
Mao JM; Liu J; Guo G; Mao XG; Li CX
Biomark Res; 2015; 3():8. PubMed ID: 26085929
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
